BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 10352881)

  • 21. Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.
    Tu J; Sun HX; Ye YP
    J Ethnopharmacol; 2008 Sep; 119(2):266-71. PubMed ID: 18692123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An experimental study of the antitumor properties of olipifat].
    Filov VA; Reztsova VV; Kil'maeva NE; Petukhov DV; Pinchuk BT
    Vopr Onkol; 2000; 46(3):332-6. PubMed ID: 10976281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine models to evaluate novel and conventional therapeutic strategies for cancer.
    Talmadge JE; Singh RK; Fidler IJ; Raz A
    Am J Pathol; 2007 Mar; 170(3):793-804. PubMed ID: 17322365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved.
    Kerbel RS
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S134-9. PubMed ID: 14508091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental systems for analysis of the malignant phenotype.
    Poste G
    Cancer Metastasis Rev; 1982; 1(2):141-99. PubMed ID: 6764376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness and limitations of murine tumor models for the identification of new antitumor agents.
    Goldin A; Johnson RK; Venditti JM
    Antibiot Chemother (1971); 1980; 28():1-7. PubMed ID: 6998358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New tumor-inhibiting metal complexes.
    Keppler BK; Berger MR; Heim ME
    Cancer Treat Rev; 1990 Sep; 17(2-3):261-77. PubMed ID: 2272042
    [No Abstract]   [Full Text] [Related]  

  • 28. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical assessment of anti-cancer therapeutic strategies using in vivo videomicroscopy.
    Chambers AF; MacDonald IC; Schmidt EE; Morris VL; Groom AC
    Cancer Metastasis Rev; 1998-1999; 17(3):263-9. PubMed ID: 10352879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal modeling of cancer pathology and studying tumor response to therapy.
    Langdon SP
    Curr Drug Targets; 2012 Nov; 13(12):1535-47. PubMed ID: 22974396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The antitumor properties of honey].
    Gribel' NV; Pashinskiĭ VG
    Vopr Onkol; 1990; 36(6):704-9. PubMed ID: 2378090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantable colon tumors as chemotherapy screening models.
    Ball CR; Double JA
    Cancer; 1975 Dec; 36(6 Suppl):2437-40. PubMed ID: 174794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineoplastic activity of azacarbazoles. II. Effect of alpha-carboline and its derivatives on transplantable animal neoplasms.
    Fiszer-Maliszewska L; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):221-4. PubMed ID: 3447536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New anticancer agents: in vitro and in vivo evaluation.
    Zips D; Thames HD; Baumann M
    In Vivo; 2005; 19(1):1-7. PubMed ID: 15796152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression.
    Lubet RA; Steele VE; Shoemaker RH; Grubbs CJ
    Cancer Prev Res (Phila); 2018 Oct; 11(10):595-606. PubMed ID: 30045934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of human Alu sequences by real-time PCR--an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants.
    Schneider T; Osl F; Friess T; Stockinger H; Scheuer WV
    Clin Exp Metastasis; 2002; 19(7):571-82. PubMed ID: 12498386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of tumor cell response to chemotherapy by the organ environment.
    Fidler IJ; Wilmanns C; Staroselsky A; Radinsky R; Dong Z; Fan D
    Cancer Metastasis Rev; 1994 Jun; 13(2):209-22. PubMed ID: 7923551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor models in drug development.
    Griswold DP; Harrison SD
    Cancer Metastasis Rev; 1991 Oct; 10(3):255-61. PubMed ID: 1764768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology of human colon cancer metastasis.
    Gutman M; Fidler IJ
    World J Surg; 1995; 19(2):226-34. PubMed ID: 7754628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulating effect of ethyl pyruvate on nonsyngenic transplanted tumor in mice.
    Bogdanova LA; Morozkova TS; Kaledin VI; Nikolin VP; Popova NA
    Bull Exp Biol Med; 2013 Oct; 155(6):785-7. PubMed ID: 24288766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.